Double-blind, Randomized, Placebo-controlled Trial Evaluating the Effect of Two Infusions Four Weeks Apart of Interleukin-6-Receptor Inhibitor (Tocilizumab) on Pain Relief in Patients With Severe Osteoarthritis of the Hand Refractory to Usual Treatment
Phase of Trial: Phase III
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms TIDOA
- 24 Nov 2016 Planned End Date changed from 1 Jul 2017 to 1 Sep 2017.
- 24 Nov 2016 Planned primary completion date changed from 1 May 2017 to 1 Jul 2017.
- 24 Nov 2016 Status changed from not yet recruiting to recruiting.